Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

RNA-seq analysis of integrin β7hi or integrin β7lo PCs, or klf2-sufficient or -deficient PCs

ABSTRACT: RNA-seq analysis of integrin β7hi or integrin β7lo PCs, or klf2-sufficient or -deficient PCs

PROVIDER: PRJNA1107186 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

RNA-seq analysis of integrin β7hi or integrin β7lo PCs, or klf2-sufficient or -deficient PCs

Project description:We found that, among newly generated IgG plasma cells, integrin b7hi marks plasma cells prone to home to the bone marrow, whereas integrin b7lo cells remain in secondary lymphoid organs. Moreover, we also found that the differences in KLF2 expression between b7hi and b7lo populations in secondary lymphoid organs is likely to explain that only integrin b7hi plasma cells can egress. Next, to look for the functional target(s) downstream of KLF2 involved in egress of newly generated plasma cells, we carried out RNA-seq analysis of KLF2-sufficient and -deficient splenic plasma cells. Wildtype control splenic plasma cells were further divided into integrin b7hi and b7lo populations. We identified S1pr1 and Itgam as functional targets downstream of KLF2.

2025-02-05 | GSE266441 | GEO

RNA-seq analysis of SPL integrin b7hi or integrin b7lo PCs, or BM PCs

Project description:RNA-seq analysis of SPL integrin b7hi or integrin b7lo PCs, or BM PCs

| PRJNA1106498 | ENA

RNA-seq analysis of SPL integrin b7hi or integrin b7lo PCs, or BM PCs

Project description:Newly generated plasma cells in secondary lymphoid organs migrate to niches in the bone marrow, wherein they survive as long-lived plasma cells (LLPCs). Although characterization of LLPCs has been well performed, it is still unclear what is key determinant(s) for longevity of plasma cells. One postulated model is that heterogeneity of plasma cells is formed by such as BCR affinity and/or microenvironment at the induction site, and some of these variables may instruct their longevity. Here, we found that, among newly generated IgG plasma cells, integrin b7hi marks plasma cells prone to home to the bone marrow, whereas integrin b7lo cells remain in secondary lymphoid organs.

2025-02-05 | GSE266284 | GEO

Lens epithelial cell transcriptome reprogramming at 24 hours post cataract surgery (PCS) in wild type (WT) and β8 integrin Conditional Knockout (β8ITGcKO) mice.

Project description:This trancriptome analysis reveals the first detailed analysis on how the remnant lens epithelial cells (LECs) greatly reprogram their transcriptome by 24 hours post cataract surgery (PCS) and the dependence of this phenomenom on endogenous β8 integrin gene expression.

2021-12-15 | GSE145492 | GEO

Trancriptional comparison of Zbtb32-deficient and -sufficient cells

Project description:Trancriptional comparison of Zbtb32-deficient and -sufficient cells

| PRJNA325278 | ENA

Transcriptional profiling by array of Klf2 wild-type and Klf2-Null mESCs cultured under 2i

Project description:The self-renewing pluripotent state was first captured in mouse embryonic stem cells (mESCs) over two decades ago. The standard condition requires the presence of serum and LIF, which provide growth promoting signals for cell expansion. However, there are pro-differentiation signals which destabilize the undifferentiated state of mESCs. The dual inhibition (2i) of the pro-differentiation Mek/Erk and Gsk3/Tcf3 pathways in mESCs is sufficient to establish an enhanced pluripotent “ground state” which bears features resembling the pre-implantation mouse epiblast. Gsk3 inhibition alleviates the repression of Esrrb, a transcription factor that can substitute for Nanog function in mESCs. The molecular mechanism that is mediated by Mek inhibition is however not clear. In this study, we investigate the pathway through which Mek inhibition operates to maintain ground state pluripotency. We have found that in mESCs, Kruppel-like factor 2 (Klf2) is a protein target of the Mek/Erk pathway; and that Klf2 protein is phosphorylated by Erk2 and subsequently degraded through the proteosome. It is therefore by Mek-inhibition through PD0325901 or 2i that enables the stabilization and accumulation of Klf2 to sustain ground state pluripotency. Importantly, we found that Klf2-null mESCs, while viable under LIF/Serum conditions, cannot be maintained and eventually gradually die within a few passages. Our result thus demonstrates that Klf2 is an essential factor of ground state pluripotency. Collectively, our study defines the Mek/Klf2 axis that cooperates with the Gsk3/Esrrb pathway in mediating ground state pluripotency.

2014-06-04 | E-MTAB-2366 | biostudies-arrayexpress

Microarray data for Bhlhe40-sufficient and -deficient resident macrophages

Project description:Microarray data for Bhlhe40-sufficient and -deficient resident macrophages

| PRJNA517406 | ENA

Transcriptome of ZFP36L1-sufficient and ZFP36L1-deficient Fo B cells

Project description:Transcriptome of ZFP36L1-sufficient and ZFP36L1-deficient Fo B cells

| PRJNA609143 | ENA

RNA sequence analysis between ECM1- sufficient and -deficient peritoneal macrophage

Project description:RNA sequence analysis between ECM1- sufficient and -deficient peritoneal macrophage

| PRJNA590877 | ENA

RNA-seq analysis of transcriptomes of Noc4L deficient and the Nco4L sufficient Treg cells

Project description:To gain in depth transcriptional information about the Noc4L deficient and Noc4L sufficient Tregs, we performed RNA-seq analysis to compare the transcriptomes of Noc4L deficient (CD4+GFP+CD62Lhigh, cKO) and Noc4L sufficient (CD4+GFP+CD62Lhigh, Het) Tregs activated in vitro with Dynabeads for 48 hours or 72 hours. We found ~25 unique genes with differential expression between the Noc4L deficient and Noc4L sufficient Treg cells when activated for 48 hours in vitro. And ~100 unique genes with differential expression between the Noc4L deficient and Noc4L sufficient Treg cells when activated for 72 hours in vitro in two times experiment.

2018-07-04 | GSE116572 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data